Topics

DNA sequencing Corporate

12:38 EDT 20th September 2019 | BioPortfolio

Frelii, Inc.

Frelii Inc. is a biotech company that uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome. The results are aligned and leveraged against its AI, as a means of creating a very strong and powerful data platform for use by the Health & Wellness, Healthcare, Medical Cannabis and Pharmaceutical industries. Frelii’s technology...

Microbiome Insights, Inc.

Microbiome Insights, Inc. is a global provider of end-to-end services for microbiome DNA sequencing and state-of-the-art bioinformatic analysis. Based in Vancouver, Canada, the company's customized suite of services enables researchers and clinicians to include microbiome analysis in studies across a range of human, animal, agricultural, and environmental ...

RevoluGen

RevoluGen is a small, UK based molecular chemistry research and development company that specialises in HMW-DNA isolation and purification from cell samples specifically for long-read sequencing applications. The combined Fire Monkey / Fire Flower product is RevoluGen’s disruptive first product. Using an innovative combination of chemistry and a spin-column process, RevoluGen has married the...

Purigen Biosystems, Inc.

Purigen Biosystems is redefining nucleic acid sample preparation with an innovative platform based on the highly efficient isotachophoresis technology invented by Juan Santiago, PhD, and his team at Stanford University. Purigen’s automated benchtop instrumentation and accompanying microfluidic chip purifies and quantitates nucleic acid samples from a ...

Nebula Genomics

Nebula Genomics is a human genome sequencing and health big data company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for its use, th...

Day Zero Diagnostics, Inc.

Day Zero Diagnostics, Inc., based in Boston, is pioneering a new class of infectious disease diagnostics using whole genome sequencing and machine learning to combat the risk of antibiotic-resistant infections. The company was founded in 2016 by a team of clinicians and scientists from Harvard University and Massachusetts General Hospital. The company is r...

4D Molecular Therapeutics, Inc.

4DMT is focused on the discovery and development of targeted, customized and proprietary next-generation AAV gene therapy products for use in patients with severe genetic diseases with high unmet medical need. 4DMT’s robust discovery platform, termed Therapeutic Vector Evolution, empowers it to create customized gene delivery vehicles that can be desi...

Quantabio

Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational and life science research. The Quantabio team leverages decades of experience in developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical P...

NextGen Jane

NextGen Jane (Jane) is a diagnostic startup focused on developing tests based off a patented tampon collection technology. Jane’s technology platform allows users to collect menstrual and cervicovaginal samples with an everyday household product, preserve nucleic acids and other analytes important for disease detection and ship them off to a lab for i...

Vela Diagnostics

Vela Diagnostics is a leading provider of an automated IVD Next–Generation Sequencing (NGS) workflow in the global diagnostics market. Vela’s real-time PCR and NGS applications are available on one integrated Sentosa® platform; this provides a unique ability for the customers to leverage one system for two workflows, while carrying out tests...

InteRNA Genomics

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and based in Bilthoven, the Netherlands, offers services and software for processing, analyzing and presenting ultra-high-throughput sequencing data generated by various platforms. InteRNA's proprietary informatics solutions, Intess(TM), convert large sets of raw sequencing data into interpretable formats and integrate this infor...

The Medical Genome Initiative

The Medical Genome Initiative is a consortium of leading clinical laboratories and research organizations in the U.S. and Canada with a mission to expand access to high-quality clinical whole genome sequencing (cWGS) for the diagnosis of genetic disease. The initial focus of the Medical Genome Initiative will be to publish recommended laboratory and clinic...

ReViral Ltd.

ReViral is a clinical-stage company focused on developing novel, anti-viral compounds that target respiratory syncytial virus (RSV). Founded in 2011, ReViral has an experienced R&D leadership team with a successful track record in antiviral drug discovery and development. The company has developed a novel antiviral programme targeting RSV fusion with highl...

Cofactor Genomics, Inc.

Cofactor Genomics uses RNA to help researchers and clinicians understand, diagnose, and predict drug response for the 95% of disease that can’t be assessed by DNA alone. Founded by three former Human Genome Project scientists, Cofactor has built a database of multidimensional gene expression models, and a proprietary platform capable of overcoming the...

Novo Integrated Sciences

Through Novo Healthnet Limited, a wholly owned subsidiary of Novo Integrated Sciences, we deliver multi-disciplinary primary healthcare to over 400,000 patients annually through our 16 corporate-owned clinics and a contracted network of 88 affiliate clinics and 234 eldercare centric homes located across Canada. Our team of practitioners and staff are train...

Celsee, Inc.

Celsee, Inc., a privately held company in the Ann Arbor, Michigan area, is breaking through the traditional barriers of single-cell analysis and delivering clinical-grade technology designed to support the life sciences revolution and precision medicine. Based on a gentle, gravity-induced, micro-well isolation technique, the patented technology forms the f...

KSQ Therapeutics

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high confidence drug development. The company is advancing a pipeline of tumor- and immune-focused drug candidates for the treatment of cancer, across multiple drug modalities including targeted therapies, adoptive cell therapies and immuno-therapies. KSQâ...

uBiome, Inc.

Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions ...

Personal Genome Diagnostics, Inc.

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequ...

Personal Genome Diagnostics Inc.

Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequ...

Quantapore Inc.

Quantapore Inc. is a biotechnology company focused on the development and commercialization of an ultra-low-cost, high-throughput DNA sequencing platform. Based in Menlo Park, CA, the company was founded in 2009 and is well on its way to the commercialization of its novel sequencing platform. The combination of low cost, long reads, simple workflow and fas...

Quantapore Incorporated

Quantapore Inc. is a biotechnology company focused on the development of an ultra-low-cost, high-throughput DNA sequencing platform. Based in Menlo Park, CA, the company was founded in 2009 and is well on its way to the commercialization of its novel sequencing platform. The combination of low cost, long reads, simple workflow and fast sample-to-results tu...

S2 Genomics, Inc.

S2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissue for life science applications. S2 Genomics’ technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample preparation solutions for the next generation sequencing (NGS) and cell biology markets...

Sonion

Sonion a/s is a Novo Holding a/s owned global leader in microacoustics and micromechanics for hearing health and other ear-level devices. The company – which is headquartered in Roskilde, Denmark - employs over 5.500 employees across sites in Denmark, Holland, USA, China, Poland, Vietnam and Philippines.

Microbiome Insights

Microbiome Insights, Inc. is a leading global provider of end-to-end services for microbiome DNA sequencing, including state-of-the-art bioinformatic analysis. Based in Vancouver, Canada, the company's customized suite of services enables researchers and clinicians to easily and effectively include microbiome analysis in studies across a range of human, an...

Quick Search

review and buy DNA sequencing market research data and corporate reports here